Table 4.
Effective group | Ineffective group | |
---|---|---|
3 months of SLIT | ||
Cases | 271 (58%) | 195 (42%) |
Endpoint symptoms | 2.6 ± 1.2∗ | 6.5 ± 2.7 |
Endpoint medication | 3.7 ± 2.1∗ | 7.3 ± 3.6 |
SMS | 7.8 ± 3.5∗ | 12.9 ± 4.3 |
6 months of SLIT | ||
Cases | 303 (65%) | 163 (35%) |
Endpoint symptoms | 2.4 ± 1.1∗ | 6.7 ± 2.8 |
Endpoint medication | 3.1 ± 1.8∗ | 7.5 ± 3.4 |
SMS | 6.9 ± 3.6∗ | 13.2 ± 4.6 |
aData presented as median values (minimum-maximum). ∗Compared with the control group, P < 0.05.